Table 1.

Outcome measures for baseline muscle samples for damaged and nondamaged groups

	Baseline Mean ± SD		P Value
Muscle Sample Characteristics	Nondamaged, n = 10	Damaged, n = 16	Between Group
Muscle phenotype (CSA and distribution)
Mean fiber CSA, µm2	4,598.01 ± 738.79	4,103.86 ± 845.17	0.13
Type 1 fiber CSA, µm2	4,549.63 ± 802.56	3,858.34 ± 730.22	0.04*
Type 2a fiber CSA, µm2	4,659.04 ± 1,212.77	4,454.00 ± 1,093.99	0.67
Type 2a/x fiber CSA, µm2	3,901.71 ± 668.10	3,770.16 ± 1040.07	0.75
Type 1 fiber frequency, %	50.57 ± 18.43	46.74 ± 11.93	0.57
Type 2a fiber frequency, %	47.22 ± 18.31	49.29 ± 11.85	0.76
Type 2a/x fiber frequency, %	2.22 ± 2.46	4.17 ± 7.33	0.35
Satellite cell content (SC)
SC/fiber	0.08 ± 0.04	0.07 ± 0.03	0.37
Total collagen content
PSR/total area (%)	5.53 ± 1.52	5.15 ± 1.33	0.53
Fractional synthesis rate (FSR)
Protein synthesis, % per day	2.18 ± 1.14	2.04 ± 1.68	0.80
RNA synthesis, % per day	0.03 ± 0.05	0.04 ± 0.05	0.58

CSA, cross-sectional area; PSR, Picrosirius red. *Significantly different between groups.